Holinergic System and Growth of Malignant Tumor
DOI:
https://doi.org/10.5644/Radovi.180Abstract
It has been shown that activators of acetylcholinetransferase — oxotremorine, recosen and K-strophantin — can suppres the growth of Ehrlich ascitcs carcinoma, sarkoma S-180 and leukaemia Ly 1210. The hypothesis has been forwarded that the cause of this effect is acetylcholine which causes growth both in health and malignant tissue.
References
Ablad, B„ Brogard M, El. L. Pharmacological properties of H 56/28 a betaadrenergic receptor antagonist. Acta Pharmacol. et Toxicol. 25 Suppl. 2, (1967).
Bašagić Enisa, Bošković B., Stern P. Activation of choline acetylase by a protein-free aqueous extract of heart tnuscle. Arch. int. Pharmacodyn, 137, 49—53 (1962).
Bonta, I.L. De Vos C. J. Gri sen H. Hillen F. C. Noach E. L., Sim A. W. -l-Hydroxy-3-amino-Pyrrolidone-2-(HA-966) a new GABA-like compound, with potential tise in extrapyramidal diseases. — Br. J. Pharmac. 43, 514—535 (1971) .
Burgen, A ,S. V., Dickens F., Zatman L. J., The action of botulimun toxin on the neuromuscular junction. J. Phvsiol. (London) 109, 10—24 (1949).
Ching-chieh Yu, Booth Gary M., Inhibition of choline acetylase from the house fly (Musca domestica L.) and mouse. Life Sciences 10, Part II, 337—347 (1971).
Crossland J., Slater P., The effect of some drugs on the "free" and »bound« acetylcholine content of rat brain. Br. J. Pharmac. Chemother. 33, 42—47 (1968).
Drachman D. B., Is acetylcholine the trophic neuromuscular transmitter? Arch. Neurol. 17, 206—218 (1967).
Drachman, D. B., Botulinum toxin as a tool for research on the nervous system. In: Simpson L. L. "Neuropoisons — their pathophysiological Actions". 1, Bisons of Animal Origin. Plenum Press, New York, London 1971, 325—347.
Goodman L. S., Gilman A. The pharmacological basis of therapeutics IV Edit. The Macmillan Comp., New York, 1970.
Gyorgy L., Gellen B., Doda M., Sterk L., Pharmacology of l-/2-Oxo-l-Pyrrolidino)-4-(2-Chloroethyl-Methylamino) but-2-yne-HCL (DSO-16). I. Acta Physiologica Academiae Scientiarum Hungaricae 40, str. 373—379
(1971).
Holmstedt B., Lundgren, G., Effects of oxotremorine and atropine on choline acetylase activity. In: E. Heilbron, A. Winter, Drugs and cholinergic mechanisms in the CNS. Research Institute of National defence, Stockholm, 1970, 339—354.
Koele G. B., Cholinesterase and Anticholinesterase Agents. Springer Verlag, Berlin (1963).
Longenecker H. E., jun. Hurlbut W. P., Mauro A., Clark A. W., Effects of black widow spider venom on the frog neuromuscular junction. Nature 225, 7011—703 (1970).
Ratković, D., Stern P., Bošković B., lleber die Wirkung des Tremorins auf die Cholinacetylase. Buli. Sc. Cons. Acad. R.P.F. Yugoslav 70, 40 (1965).
Schmitz, G. Gross R., Erste klinische Erfahrungen mit ulrtahohen Einzeldosen von Cyclophosphamid. Die Medizinische Welt 18, 985—989 (1967).
Stern P., Utjecaj medijatora na rast malignih tumora. RADOVI (u štampi).
Švec F., privatno saopštenje.
Taylor R. J., Stubbs C. S., Ellenbogen L. Jr. Tyrosine hydroxylase inhibition in vitro and in vivo by chelating agents. Biochemical. Pharmacol. 18, 587—594 (1969).
Tripod J., Tierexperimenteller Nachweis der Affinitdt von Desferal fur Eisen. Schweiz. med. Wschrift. 93, 969—973 (1963).
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Pavel Štern
This work is licensed under a Creative Commons Attribution 4.0 International License.
